Komipharm International Co., Ltd. (KOSDAQ:041960)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Veterinary Medicine Manufacturing and Sales			42.65B	39.80B	35.85B	37.16B	35.49B
Veterinary Medicine Manufacturing and Sales Growth			7.15%	11.03%	-3.53%	4.71%	1.42%
Total			42.65B	39.80B	35.85B	37.16B	35.49B
Total Growth			7.15%	11.03%	-3.53%	4.71%	1.42%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			27.25B	24.43B	23.67B	21.92B	22.40B
South Korea Growth			11.56%	3.21%	7.96%	-2.12%	-2.95%
Overseas			15.39B	15.37B	12.18B	15.24B	13.09B
Overseas Growth			0.15%	26.22%	-20.08%	16.38%	9.88%
Total			42.65B	39.80B	35.85B	37.16B	35.49B
Total Growth			7.15%	11.03%	-3.53%	4.71%	1.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error